1[1]Festa A, D′ Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome:the Insulin Resistance Atherosclerosis Study (IRAS) [ J ]. Circulation, 2000,102: 42 - 47
2[2]Rader DJ. Inflammatory markers of coronary risk[J].N Engl N Med,2000,343:1179-1182
3[3]Pearson TA, Mensah GA,Alexander RW,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association [ J ]. Circulation, 2003, 107: 499 -511
4[4]Rubins HB, Robins SWJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high - density lipoprotein cholesterol. Veterans Affairs High - Density Lipoprorein Cholesterol Intervention Trial Study Croup[J ]. N Engl J Med, 1999,341:410 - 418
10The AHA in Collaboration with the Internation Lisaison Committee on kesuscitatioll Part T:the era of reperfusion section:acute coronary sytromes.Circulation,2006,102:172.
